RadNet, Inc.
NASDAQ:RDNTMedical - Diagnostics & Research
+$1.53 today
- Market cap
- $5.66B
- Beta
- 1.39
- P/E (TTM)
- -295.1
- EPS (TTM)
- -$0.18
Volume 0.81M
Average 0.80M
RDNT Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
RadNet, Inc.NASDAQ: RDNT
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures dips below year-ago levels
Q3 FY2026 capital expenditures of $55.51M (cash outflow) fell 8.2% year over year, behind the +142.2% change in trailing-twelve-month capital expenditures. Sequentially, it fell 1.4% from the prior quarter. Over 3 fiscal years it compounded at -5.1% a year.
Context
- Capital expenditures amounted to 10.5% of revenue in FY2025, up 0.2 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -8.2% toward the trailing-twelve-month pace of +142.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (213.25M) USD
- Year-over-year change
- -13.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (213.25M) | -13.4% |
| FY2024 | 2024-12-31 | (188.07M) | -6.5% |
| FY2023 | 2023-12-31 | (176.6M) | +29.2% |
| FY2022 | 2022-12-31 | (249.41M) | -13.0% |
| FY2021 | 2021-12-31 | (220.7M) | — |
Capital Expenditures vs competitors
How RDNT compares with its peers on the latest reported figures
- RDNT's LTM Sep 2026 capital expenditures of $496.75M is the 2nd largest of the 7 companies compared; the peer median is $14.16M.
- Its year-over-year change of +142.2% is the highest of 7, against a peer median of +3.0%.
- Capital expenditures amounts to 20.8% of revenue for RDNT, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $522M | +21.4% | +15.8% | 2.6% | |
| LTM Sep 2026 | $496.75M | +142.2% | -5.1% | 20.8% | |
| LTM Jun 2026 | $96.5M | -17.2% | -2.4% | 2.8% | |
LMRILumexa Imaging Holdings, Inc. Common Stock | FY2025 | $23.48M | -15.5% | — | 2.3% |
| LTM Mar 2026 | $4.85M | -59.7% | +60.6% | 5.6% | |
| LTM Dec 2025 | $4.45M | +61.0% | -16.3% | 34.2% | |
| LTM Mar 2026 | $3.95M | +106.7% | -43.2% | 3.8% | |
| Peer median (excluding RDNT) | $14.16M | +3.0% | -2.4% | 3.3% | |
Competitors are the stored peer set for RDNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 44.32M | 33.61M | 30.34M | 38.84M | 46.77M |
| Depreciation & Amortization | 170.66M | 184.72M | 189.49M | 137.84M | 152.13M |
| Deferred Income Tax | (21.49M) | 13.36M | 0 | 0 | 10.83M |
| Stock-Based Compensation | 25.2M | 23.77M | 26.79M | 29.83M | 54.6M |
| Change in Working Capital | (92.13M) | (58.7M) | (40.27M) | (56.49M) | (9.75M) |
| Accounts Receivables | (5.89M) | (30.08M) | 2.65M | (21.77M) | (9.56M) |
| Inventory | (87.67M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 9.92M | 49.78M | 15.09M | 37.12M | 52.42M |
| Other Working Capital | (8.49M) | (78.4M) | (58.01M) | (71.84M) | (52.61M) |
| Other Non-Cash Items | 22.93M | (50.35M) | 14.52M | 83M | 44.24M |
| Operating Cash Flow | 149.49M | 146.42M | 220.86M | 233.02M | 298.82M |
| Capital Expenditures | (220.7M) | (249.41M) | (176.6M) | (188.07M) | (213.25M) |
| Acquisitions (Net) | (1.44M) | (1.44M) | (24.95M) | (45.16M) | (133.42M) |
| Purchases of Investments | (1.44M) | (1.44M) | 0 | 0 | 0 |
| Sales of Investments | 1.44M | 1.44M | 0 | 0 | 0 |
| Other Investing Activities | 625K | 3.9M | 83K | 157K | 2.81M |
| Investing Cash Flow | (221.51M) | (246.95M) | (201.47M) | (233.07M) | (343.87M) |
| Debt Repayment | 94.48M | 94.25M | (43.99M) | 165.33M | 71.22M |
| Common Stock Issued | 488K | 294K | 245.83M | 218.39M | 5.45M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.71M | (893K) | (6.2M) | 14.23M | (4.46M) |
| Financing Cash Flow | 104.67M | 93.65M | 195.64M | 397.95M | 72.21M |
| Effect of Forex Changes | (65K) | 113K | (292K) | (453K) | 33K |
| Net Change in Cash | 32.59M | (6.77M) | 214.74M | 397.45M | 27.2M |
| Free Cash Flow | (71.2M) | (103M) | 44.26M | 44.95M | 85.57M |
RadNet, Inc.
NASDAQ:RDNT
Intrinsic Alpha fair value
Locked
Current Price
$71.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.